标题
Pharmaco-Immunomodulatory Therapy in COVID-19
作者
关键词
-
出版物
DRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-21
DOI
10.1007/s40265-020-01367-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- On the use of corticosteroids for 2019-nCoV pneumonia
- (2020) Lianhan Shang et al. LANCET
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization
- (2020) Lina Chen et al. PLoS One
- Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
- (2020) Jesús Villar et al. Lancet Respiratory Medicine
- Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief
- (2020) Azfar Athar Ishaqui et al. Expert Review of Respiratory Medicine
- Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
- (2020) Achille Aouba et al. ANNALS OF THE RHEUMATIC DISEASES
- Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
- (2020) Omer Gendelman et al. AUTOIMMUNITY REVIEWS
- Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
- (2020) Jaume Alijotas-Reig et al. AUTOIMMUNITY REVIEWS
- Convalescent plasma in Covid-19: Possible mechanisms of action
- (2020) Manuel Rojas et al. AUTOIMMUNITY REVIEWS
- COVID-19 infection: the perspectives on immune responses
- (2020) Yufang Shi et al. CELL DEATH AND DIFFERENTIATION
- Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
- (2020) George Dimopoulos et al. Cell Host & Microbe
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Colchicine may not be effective in COVID-19 infection; it may even be harmful?
- (2020) Medine Cumhur Cure et al. CLINICAL RHEUMATOLOGY
- Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
- (2020) Waleed Alhazzani et al. CRITICAL CARE MEDICINE
- Cytokine storm intervention in the early stages of COVID-19 pneumonia
- (2020) Xinjuan Sun et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports
- (2020) Valeria Gaspari et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
- (2020) Christian A. Devaux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
- (2020) Zahra Sahraei et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
- (2020) Dan Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
- (2020) Yun Xie et al. JOURNAL OF INFECTION
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
- (2020) Marc Feldmann et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Considerations for Statin Therapy in Patients with COVID‐19
- (2020) Simin Dashti‐Khavidaki et al. PHARMACOTHERAPY
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?
- (2020) Pierre Tiberghien et al. VOX SANGUINIS
- Covid-19: what treatments are being investigated?
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
- (2020) Wei Cao et al. Open Forum Infectious Diseases
- Type 1 interferons as a potential treatment against COVID-19
- (2020) Erwan Sallard et al. ANTIVIRAL RESEARCH
- Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine
- (2020) Srinivasa Reddy Bonam et al. Autophagy
- Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
- (2020) Alan A. Nguyen et al. CLINICAL IMMUNOLOGY
- Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19
- (2020) Gregory Curfman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
- (2020) Yhojan Rodríguez et al. JOURNAL OF AUTOIMMUNITY
- Early safety indicators of COVID-19 convalescent plasma in 5000 patients
- (2020) Michael J. Joyner et al. JOURNAL OF CLINICAL INVESTIGATION
- Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
- (2020) Lang Wang et al. JOURNAL OF INFECTION
- Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection
- (2020) Anuradha Lala et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
- (2020) Anton De Spiegeleer et al. Journal of the American Medical Directors Association
- A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
- (2020) Federico Alberici et al. KIDNEY INTERNATIONAL
- Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
- (2020) John R. Giudicessi et al. MAYO CLINIC PROCEEDINGS
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19
- (2020) Sarah C.J. Jorgensen et al. PHARMACOTHERAPY
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Broad-spectrum coronavirus antiviral drug discovery
- (2019) Allison L. Totura et al. Expert Opinion on Drug Discovery
- Macrolides in critically ill patients with Middle East Respiratory Syndrome
- (2019) Yaseen M. Arabi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Emerging Therapies in the Treatment of Early Childhood Wheeze
- (2019) Elissa M. Abrams et al. Pediatric Allergy Immunology and Pulmonology
- Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib
- (2019) Elena Maria Elli et al. Frontiers in Oncology
- Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line
- (2019) Chang-Hung Kuo et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score-matching analysis of prospectively collected data at a single center
- (2018) Kodai Kawamura et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Group 2 Innate Lymphoid Cells in Pulmonary Immunity and Tissue Homeostasis
- (2018) Barbara C. Mindt et al. Frontiers in Immunology
- IVIG-mediated effector functions in autoimmune and inflammatory diseases
- (2017) Caroline Galeotti et al. INTERNATIONAL IMMUNOLOGY
- Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
- (2017) Sara Trabanelli et al. Nature Communications
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- The relative balance of GM-CSF and TGF-β1 regulates lung epithelial barrier function
- (2015) Christian E. Overgaard et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
- (2015) Grant S. Schulert et al. Annual Review of Medicine
- Angiotensin II in inflammation, immunity and rheumatoid arthritis
- (2015) Y. Chang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Colchicine as an anti-inflammatory and cardioprotective agent
- (2015) Armen Yuri Gasparyan et al. Expert Opinion on Drug Metabolism & Toxicology
- Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
- (2015) Palash Bhattacharya et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection: FIG 1
- (2015) Shu Yuan mBio
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
- (2015) Yaseen Arabi et al. SpringerPlus
- Inhaled Granulocyte/Macrophage Colony–Stimulating Factor as Treatment of Pneumonia-associated Acute Respiratory Distress Syndrome
- (2014) Susanne Herold et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
- (2014) Xiao Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
- (2014) Aline Schögler et al. EUROPEAN RESPIRATORY JOURNAL
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
- (2014) Ali S Omrani et al. LANCET INFECTIOUS DISEASES
- The immunomodulatory effects of statins in community-acquired pneumonia: A systematic review
- (2013) D.P.R. Troeman et al. JOURNAL OF INFECTION
- Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
- (2013) M. L. DeDiego et al. JOURNAL OF VIROLOGY
- Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases
- (2012) Lisa Kaly et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Azithromycin and the Risk of Cardiovascular Death
- (2012) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
- (2011) I. F. Hung et al. CLINICAL INFECTIOUS DISEASES
- Hydroxychloroquine: From Malaria to Autoimmunity
- (2011) Ilan Ben-Zvi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury*
- (2011) Robert Paine et al. CRITICAL CARE MEDICINE
- Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice
- (2011) Jincun Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease
- (2010) Chris Tikellis et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Immunomodulation in the critically ill
- (2009) N.R. Webster et al. BRITISH JOURNAL OF ANAESTHESIA
- Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains
- (2009) Jesus F. Bermejo-Martin et al. Journal of Infection in Developing Countries
- Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
- (2008) Carmela De Santo et al. JOURNAL OF CLINICAL INVESTIGATION
- Modulation of TNF- -converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF- production and facilitates viral entry
- (2008) S. Haga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
- (2008) Timothy Sheahan et al. PLoS Pathogens
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started